Molecular characterization of human enteroviruses in the central african republic: Uncovering wide diversity and identification of a new human enterovirus A71 genogroup

Journal of Clinical Microbiology

Volumn 50, Issue 5, 2012, Pages 1650-1658

  Bessaud, Maël ^a,b,e   Pillet, Sylvie ^c   Ibrahim, Wafa ^c   Joffret, Marie Line ^a,b   Pozzetto, Bruno ^c   Delpeyroux, Francis ^a,b   Gouandjika Vasilached, Ionela ^d  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

^d INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^e Aix Marseille University IRD 190 Inserm 1207   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRAL AFRICAN REPUBLIC; CONTROLLED STUDY; CORRELATION ANALYSIS; ENTEROVIRUS; ENTEROVIRUS A71; FECES ANALYSIS; FLACCID PARALYSIS; GENE SEQUENCE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SPECIES DIFFERENTIATION; SPECIES DIVERSITY; UNINDEXED SEQUENCE; VIRUS CHARACTERIZATION; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN;

CENTRAL AFRICAN REPUBLIC; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FECES; GENETIC VARIATION; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; PARALYSIS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

EID: 84859966860     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06657-11     Document Type: Article

References (68)

1. Abzug MJ. 2009. Enterovirus 71: emergence of the new poliomyelitis. S. Afr. J. Epidemiol. Infect. 24:5-8.
2. Anonymous. 2004. Isolation and identification of polioviruses, p 87-100. In Polio laboratory manual. World Health Organization, Geneva, Switzerland.
3. Anonymous. 2010. Non-PV enterovirus and human parechovirus surveillance - United States, 2006-2008. MMWR Morb. Mortal. Wkly. Rep. 59:1577-1580.
4. Anonymous. 2011. Update on vaccine-derived polioviruses - worldwide, July 2009-March 2011. MMWR Morb. Mortal. Wkly. Rep. 60:846-850.
5. Anonymous. 2011. Wild poliovirus 2005-2011. World Health Organization, Geneva, Switzerland. http://www.polioeradication.org/Portals/0/Document/ Data&Monitoring/Wild-poliovirus-list-2005-2011-08Nov.pdf.
6. Antona D, et al. 2007. Surveillance of enteroviruses in France, 2000-2004. Eur. J. Clin. Microbiol. Infect. Dis. 26:403-412. (Pubitemid 46873000)
7. Arita M, et al. 2005. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J. Virol. 79:12650-12657. (Pubitemid 41433184)
8. Bahri O, et al. 2005. Enteroviruses in Tunisia: virological surveillance over 12 years (1992-2003). J. Med. Microbiol. 54:63-69.
9. Bailly JL, et al. 2009. Phylogeography of circulating populations of human echovirus 30 over 50 years: nucleotide polymorphism and signature of purifying selection in the VP1 capsid protein gene. Infect. Genet. Evol. 9:699-708.
10. Bailly JL, et al. 2011. Repeated genomic transfers from echovirus 30 to echovirus 6 lineages indicate co-divergence between co-circulating populations of the two human enterovirus serotypes. Infect. Genet. Evol. 11: 276-289.
11. Bessaud M, et al. 2008. Characterization of the genome of human enteroviruses: design of generic primers for amplification and sequencing of different regions of the viral genome. J. Virol. Methods 149:277-284.
12. Bessaud M, Joffret ML, Holmblat B, Razafindratsimandresy R, Delpeyroux F. 2011. Genetic relationship between cocirculating human enteroviruses species C. PLoS One 6:e24823.
13. Bingjun T, et al. 2008. Molecular typing and epidemiology of non-PV enteroviruses isolated from Yunnan Province, the People's Republic of China. J. Med. Virol. 80:670-679. (Pubitemid 351358566)
14. Blomqvist S, Bruu AL, Stenvik M, Hovi T. 2003. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. J. Gen. Virol. 84:573-580. (Pubitemid 36267130)
15. Blomqvist S, et al. 2010. Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1. Virus Res. 151:246-251.
16. Bouslama L, et al. 2007. Natural recombination event within the capsid genomic region leading to a chimeric strain of human enterovirus B. J. Virol. 81:8944-8952. (Pubitemid 47311438)
17. Brown BA, et al. 2009. Resolving ambiguities in genetic typing of human enterovirus species C clinical isolates and identification of enterovirus 96, 99 and 102. J. Gen. Virol. 90:1713-1723.
18. Brown BA, Oberste MS, Alexander JP, Jr, Kennett ML, Pallansch MA. 1999. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 73:9969-9975.
19. Bryden AS. 1992. Isolation of enteroviruses and adenoviruses in continuous simian cell lines. Med. Lab. Sci. 49:60-65.
20. Caro V, Guillot S, Delpeyroux F, Crainic R. 2001. Molecular strategy for 'serotyping' of human enteroviruses. J. Gen. Virol. 82:79-91. (Pubitemid 32045798)
21. Chakraborty R, et al. 2004. An epidemic of enterovirus 71 infection among HIV-1-infected orphans in Nairobi. AIDS 18:1968-1970. (Pubitemid 39313218)
22. Combelas N, Holmblat B, Joffret ML, Colbere-Garapin F, Delpeyroux F. 2011. Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence. Viruses 3:1460-1484.
23. Dedepsidis E, et al. 2008. Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant. FEMS Immunol. Med. Microbiol. 52:343-351. (Pubitemid 351420751)
24. Deshpande JM, Nadkarni SS, Francis PP. 2003. Enterovirus 71 isolated from a case of acute flaccid paralysis in India represents a new genotype. Curr. Sci. 84:1350-1353. (Pubitemid 39160672)
25. Harvala H, et al. 2011. Detection and genetic characterization of enteroviruses circulating among wild populations of chimpanzees in Cameroon: relationship with human and simian enteroviruses. J. Virol. 85:4480-4486.
26. Heim A. 2005. From poliovirus surveillance to enterovirus surveillance: a complete picture? J. Med. Microbiol. 54:1-2.
27. Hu YF, et al. 2011. Complete genome analysis of coxsackievirus A2, a4, a5, and a10 strains isolated from hand, foot, and mouth disease patients in China revealing frequent recombination of human enterovirus A. J. Clin. Microbiol. 49:2426-2434.
28. Iwai M, et al. 2006. Molecular epidemiology of echoviruses 11 and 13, based on an environmental surveillance conducted in Toyama Prefecture, 2002-2003. Appl. Environ. Microbiol. 72:6381-6387. (Pubitemid 44414674)
29. Jegouic S, et al. 2009. Recombination between polioviruses and cocirculating coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses. PLoS Pathog. 5:e1000412.
30. Joffret ML, et al. Common and diverse features of co-circulating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children. J. Infect. Dis., in press.
31. Junttila N, et al. 2007. New enteroviruses, EV-93 and EV-94, associated with acute flaccid paralysis in the Democratic Republic of the Congo. J. Med. Virol. 79:393-400. (Pubitemid 46355439)
32. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. 2005. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 59:587-635. (Pubitemid 41507443)
33. Khetsuriani N, Lamonte A, Oberste MS, Pallansch M. 2006. Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983-2003. Pediatr. Infect. Dis. J. 25:889-893. (Pubitemid 44510581)
34. Kincaid O, Lipton HL. 2006. Viral myelitis: an update. Curr. Neurol. Neurosci. Rep. 6:469-474. (Pubitemid 44742114)
35. Kyriakopoulou Z, et al. 2010. Molecular identification and full genome analysis of an echovirus 7 strain isolated from the environment in Greece. Virus Genes 40:183-192.
36. Manirakiza A, Picard E, Ngbale R, Menard D, Gouandjika-Vasilache I. 2010. OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic. BMC Res. Notes 3:136.
37. Martín J, et al. 2002. Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J. Virol. 76:10921-10928. (Pubitemid 35176209)
38. Mehrabi Z, et al. 2011. Molecular detection of different types of non-PV enteroviruses in acute flaccid paralysis cases and healthy children, a pilot study. J. Clin. Virol. 50:181-182.
39. Minor P. 2009. Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication. Vaccine 27:2649 -2652.
40. Mueller JE, et al. 2009. Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Cordoba Province, Argentina. Appl. Environ. Microbiol. 75:1395-1401.
41. Nasri D, et al. 2007. Typing of human enterovirus by partial sequencing of VP2. J. Clin. Microbiol. 45:2370-2379. (Pubitemid 47295461)
42. Nasri D, et al. 2007. Basic rationale, current methods and future directions for molecular typing of human enterovirus. Expert Rev. Mol. Diagn. 7:419-434. (Pubitemid 47066556)
43. Nix WA, Oberste MS, Pallansch MA. 2006. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J. Clin. Microbiol. 44:2698-2704. (Pubitemid 44228559)
44. Norder H, Bjerregaard L, Magnius LO. 2001. Homotypic echoviruses share aminoterminal VP1 sequence homology applicable for typing. J. Med. Virol. 63:35-44.
45. Oberste MS, et al. 1999. Typing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol. 37:1288-1293. (Pubitemid 29187785)
46. Oberste MS, Maher K, Kilpatrick DR, Pallansch MA. 1999. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J. Virol. 73:1941-1948. (Pubitemid 29098095)
47. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. 2010. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 9:1097-1105.
48. Palacios G, Oberste MS. 2005. Enteroviruses as agents of emerging infectious diseases. J. Neurovirol. 11:424-433. (Pubitemid 43064681)
49. Racaniello VR. 2007. Picornaviridae: the viruses and their replication, p 795-838. In Knipe DM (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
50. Rakoto-Andrianarivelo M, et al. 2007. Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar. PLoS Pathog. 3:e191.
51. Rakoto-Andrianarivelo M, et al. 2008. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J. Infect. Dis. 197:1427-1435. (Pubitemid 351706467)
52. Rakoto-Andrianarivelo M, et al. 2005. High frequency of human enterovirus species C circulation in Madagascar. J. Clin. Microbiol. 43:242-249. (Pubitemid 40096307)
53. Roth B, Enders M, Arents A, Pfitzner A, Terletskaia-Ladwig E. 2007. Epidemiologic aspects and laboratory features of enterovirus infections in Western Germany, 2000-2005. J. Med. Virol. 79:956-962. (Pubitemid 46871554)
54. Rousset D, et al. 2003. Recombinant vaccine-derived poliovirus in Madagascar. Emerg. Infect. Dis. 9:885-887.
55. Saad M, et al. 2005. Acute flaccid paralysis: the spectrum of a newly recognized complication of West Nile virus infection. J. Infect. 51:120-127. (Pubitemid 40984346)
56. Savolainen-Kopra C, Blomqvist S. 2010. Mechanisms of genetic variation in polioviruses. Rev. Med. Virol. 20:358-371.
57. Schuffenecker I, et al. 2011. Epidemiology of human enterovirus 71 infections in France, 2000-2009. J. Clin. Virol. 50:50-56.
58. Solomon T, et al. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 10:778-790.
59. Tamura K, et al. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739.
60. Tan CY, et al. 2011. A retrospective overview of enterovirus infection diagnosis and molecular epidemiology in the public hospitals of Marseille, France (1985-2005). PLoS One 6:e18022.
61. Tao Z, et al. 2010. Isolation of a recombinant type 3/type 2 poliovirus with a chimeric capsid VP1 from sewage in Shandong, China. Virus Res. 150:56-60.
62. Tee KK, et al. 2010. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J. Virol. 84:3339-3350.
63. Thoelen I, et al. 2004. Analysis of the serotype and genotype correlation of VP1 and the 5= noncoding region in an epidemiological survey of the human enterovirus B species. J. Clin. Microbiol. 42:963-971. (Pubitemid 38332811)
64. Trallero G, et al. 2010. Enteroviruses in Spain over the decade 1998-2007: virological and epidemiological studies. J. Clin. Virol. 47:170-176.
65. Tseng FC, et al. 2007. Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data. J. Med. Virol. 79:1850-1860.
66. van der Sanden S, van der Avoort H, Lemey P, Uslu G, Koopmans M. 2010. Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses. J. Gen. Virol. 91:1949-1958.
67. Wong M, Connolly AM, Noetzel MJ. 1999. Poliomyelitis-like syndrome associated with Epstein-Barr virus infection. Pediatr. Neurol. 20:235-237. (Pubitemid 29166470)
68. Zhang Y, et al. 2010. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis. J. Gen. Virol. 91:421-429.